![](/img/cover-not-exists.png)
P-122Phase I study of S-1, irinotecan plus oxaliplatin combination therapy (S-IROX) for Unresectable pancreatic ductal adenocarcinoma
Sasaki, M., Ueno, H., Shiba, S., Hosoi, H., Akihiro, O., Sakamoto, Y., Kondo, S., Morizane, C., Okusaka, T.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw199.116
Date:
June, 2016
File:
PDF, 62 KB
2016